Literature DB >> 8550215

Rapid cyclic changes in density and accessibility of endometrial ligands for Escherichia coli Dr fimbriae.

A K Kaul1, D Kumar, M Nagamani, P Goluszko, S Nowicki, B J Nowicki.   

Abstract

The mechanisms of developing infection in young, noncompromised individuals are well understood. Colonization is prerequisite for the development of infection. In human, ligands serving bacterial colonization belong to common antigens. Consequently, a majority of individuals should be sensitive to infection at all times. We hypothesize that the temporal patterns of some infections and sensitivity to them are associated with sudden changes in the density and accessibility of common receptors. Endometrial samples from women having normal menstrual cycles were examined for histological location, receptor density, and in situ hybridization of Dr (decaying-accelerating factor) ligands for Escherichia coli Dr fimbriae. Significant up-regulation and luminal expression of Dr ligands occurred during the secretory phase, whereas receptors were expressed in the basement membrane and in smaller quantities during the proliferative phase. This observation agrees with our hypotheses that some ligands recognized by bacterial adhesins change their compartmentalization and, most importantly, that they up-regulate expression at specific times.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8550215      PMCID: PMC173809          DOI: 10.1128/iai.64.2.611-615.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  A genetic basis for resistance to enteric disease caused by E. coli.

Authors:  J M Rutter; M R Burrows; R Sellwood; R A Gibbons
Journal:  Nature       Date:  1975-09-11       Impact factor: 49.962

2.  Quantitation of estrogen receptor content and Ki-67 staining in breast carcinoma by the microTICAS image analysis system.

Authors:  W A Franklin; M Bibbo; M I Doria; H E Dytch; J Toth; E DeSombre; G L Wied
Journal:  Anal Quant Cytol Histol       Date:  1987-08       Impact factor: 0.302

3.  Pelvic inflammatory disease in adolescents.

Authors:  R S Gibbs
Journal:  Tex Med       Date:  1987-02

4.  Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system.

Authors:  A Nicholson-Weller; J Burge; D T Fearon; P F Weller; K F Austen
Journal:  J Immunol       Date:  1982-07       Impact factor: 5.422

5.  An evaluation of gonorrhea case findings in the chronically infected female.

Authors:  D W Johnson; K K Holmes; P A Kvale; C W Halverson; W P Hirsch
Journal:  Am J Epidemiol       Date:  1969-11       Impact factor: 4.897

6.  Decreased expression of endometrial decay accelerating factor (DAF), a complement regulatory protein, in patients with luteal phase defect.

Authors:  A Kaul; M Nagamani; B Nowicki
Journal:  Am J Reprod Immunol       Date:  1995-10       Impact factor: 3.886

Review 7.  Bacterial adherence: adhesin-receptor interactions mediating the attachment of bacteria to mucosal surface.

Authors:  E H Beachey
Journal:  J Infect Dis       Date:  1981-03       Impact factor: 5.226

8.  The occurrence of chlamydial and gonococcal salpingitis during the menstrual cycle.

Authors:  R L Sweet; M Blankfort-Doyle; M O Robbie; J Schacter
Journal:  JAMA       Date:  1986-04-18       Impact factor: 56.272

9.  Effect of menstrual cycle and method of contraception on recovery of Neisseria gonorrhoeae.

Authors:  W M McCormack; G H Reynolds
Journal:  JAMA       Date:  1982-03-05       Impact factor: 56.272

10.  Microbiology and pathogenesis of acute salpingitis as determined by laparoscopy: what is the appropriate site to sample?

Authors:  R L Sweet; D L Draper; J Schachter; J James; W K Hadley; G F Brooks
Journal:  Am J Obstet Gynecol       Date:  1980-12-01       Impact factor: 8.661

View more
  8 in total

Review 1.  Pathogenesis of Afa/Dr diffusely adhering Escherichia coli.

Authors:  Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

Review 2.  Pathogenesis of human diffusely adhering Escherichia coli expressing Afa/Dr adhesins (Afa/Dr DAEC): current insights and future challenges.

Authors:  Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

3.  Dra/AfaE adhesin of uropathogenic Dr/Afa+ Escherichia coli mediates mortality in pregnant rats.

Authors:  K Wroblewska-Seniuk; R Selvarangan; A Hart; R Pladzyk; P Goluszko; A Jafari; L du Merle; S Nowicki; C Yallampalli; C Le Bouguénec; B Nowicki
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

4.  Epithelial invasion by Escherichia coli bearing Dr fimbriae is controlled by nitric oxide-regulated expression of CD55.

Authors:  Li Fang; Bogdan J Nowicki; Petri Urvil; Pawel Goluszko; Stella Nowicki; Steven L Young; Chandrasekhar Yallampalli
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

5.  Preterm labor: CD55 in maternal blood leukocytes.

Authors:  Stella Nowicki; Michael G Izban; Edyta Pawelczyk; Vincent K Agboto; Siddarth Pratap; Gayle Olson; Bogdan Nowicki
Journal:  Am J Reprod Immunol       Date:  2009-05       Impact factor: 3.886

6.  PI3K/Akt pathway restricts epithelial adhesion of Dr + Escherichia coli by down-regulating the expression of decay accelerating factor.

Authors:  Manu Banadakoppa; Pawel Goluszko; Daniel Liebenthal; Bogdan J Nowicki; Stella Nowicki; Chandra Yallampalli
Journal:  Exp Biol Med (Maywood)       Date:  2014-03-05

7.  Urinary Tract Infection in Pregnant Women: Old Dogmas and Current Concepts Regarding Pathogenesis.

Authors:  Bogdan Nowicki
Journal:  Curr Infect Dis Rep       Date:  2002-12       Impact factor: 3.663

8.  A shear stress micromodel of urinary tract infection by the Escherichia coli producing Dr adhesin.

Authors:  Beata Zalewska-Piątek; Marcin Olszewski; Tomasz Lipniacki; Sławomir Błoński; Miłosz Wieczór; Piotr Bruździak; Anna Skwarska; Bogdan Nowicki; Stella Nowicki; Rafał Piątek
Journal:  PLoS Pathog       Date:  2020-01-09       Impact factor: 6.823

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.